Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Capitalization 301B P/E ratio 2024 *
15.7x
P/E ratio 2025 * 13.1x
Enterprise value 322B EV / Sales 2024 *
5.02x
EV / Sales 2025 * 4.49x
Free-Float
70.84%
Yield 2024 *
2.59%
Yield 2025 * 2.73%
More valuation ratios * Estimated data
Dynamic Chart
1 day+2.41%
1 week+0.96%
Current month+0.12%
1 month+5.59%
3 months-8.39%
6 months-3.45%
Current year+8.78%
More quotes
1 week
114.47
Extreme 114.47
120.07
1 month
110.72
Extreme 110.72
120.07
Current year
109.16
Extreme 109.16
134.63
1 year
99.14
Extreme 99.14
134.63
3 years
70.89
Extreme 70.89
134.63
5 years
65.25
Extreme 65.25
134.63
10 years
45.69
Extreme 45.69
134.63
More quotes
Director TitleAgeSince
Chief Executive Officer 57 14-03-31
Director of Finance/CFO 55 89-12-31
Chief Tech/Sci/R&D Officer 55 20-07-31
Manager TitleAgeSince
Director/Board Member 63 07-11-26
Director/Board Member 71 95-08-31
Chief Executive Officer 57 14-03-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+2.41%+0.96%+10.31%+53.49%301B
-3.55%-2.92%+63.52%+251.69%822B
-2.16%-4.01%+33.76%+181.19%583B
-1.42%+0.46%+2.68%-5.74%397B
-2.11%-1.19%+32.01%+72.78%341B
-3.88%-5.53%+16.80%+47.37%256B
-1.07%-3.22%+8.78%-24.28%262B
-1.99%-2.95%+12.67%+18.64%236B
-1.90%-2.01%+27.70%+43.29%174B
+0.42%-0.73%-19.42%-39.13%162B
Average -0.88%-2.11%+18.88%+59.93% 353.35B
Weighted average by Cap. -0.78%-2.29%+27.80%+102.57%
See all sector performances
2024 *2025 *
Net sales 64.14B 68.45B
Net income 18.99B 22.87B
Net Debt 21.28B 6.91B
More financial data * Estimated data
Logo Merck & Co., Inc.
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Employees
71,000
More about the company
Date Price Change Volume
24-09-05 118.59 $ +2.41% 12,009,664
24-09-04 115.80 $ -0.67% 7,693,362
24-09-03 116.58 $ -1.58% 7,640,303
24-08-30 118.45 $ +0.84% 8,876,478
24-08-29 117.46 $ +0.05% 7,202,452

Delayed Quote Nyse, September 05, 2024 at 04:00 pm EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
118.59USD
Average target price
139.22USD
Spread / Average Target
+17.39%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW